EGA
NVO

Eagle Global Advisors’s Novo Nordisk NVO Stock Holding History

Eagle Global Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Hold
6,205
– – 0.01% 240
2026
Q1 		$228K Sell
6,205
-67,646
-92% -$3.21M 0.01% 261
2025
Q4 		$3.76M Sell
73,851
-3,347
-4% -$171K 0.14% 108
2025
Q3 		$4.28M Sell
77,198
-28,110
-27% -$1.65M 0.16% 101
2025
Q2 		$7.27M Sell
105,308
-1,040
-1% -$70.7K 0.29% 73
2025
Q1 		$7.38M Sell
106,348
-3,780
-3% -$312K 0.3% 70
2024
Q4 		$9.47M Buy
110,128
+315
+0.3% +$34.1K 0.39% 60
2024
Q3 		$13.1M Sell
109,813
-785
-0.7% -$105K 0.65% 38
2024
Q2 		$15.8M Sell
110,598
-1,259
-1% -$167K 0.83% 31
2024
Q1 		$14.4M Sell
111,857
-13,858
-11% -$1.65M 0.81% 33
2023
Q4 		$13M Sell
125,715
-240
-0.2% -$23.7K 0.79% 34
2023
Q3 		$11.5M Sell
125,955
-529
-0.4% -$46.6K 0.74% 36
2023
Q2 		$10.2M Sell
126,484
-6,480
-5% -$529K 0.67% 44
2023
Q1 		$10.6M Sell
132,964
-28,868
-18% -$2.05M 0.71% 44
2022
Q4 		$11M Sell
161,832
-2,124
-1% -$125K 0.75% 39
2022
Q3 		$8.17M Sell
163,956
-1,890
-1% -$101K 0.61% 49
2022
Q2 		$9.24M Sell
165,846
-818
-0.5% -$45.4K 0.68% 43
2022
Q1 		$9.25M Buy
166,664
+410
+0.2% +$21K 0.57% 52
2021
Q4 		$9.31M Buy
166,254
+290
+0.2% +$15.7K 0.59% 53
2021
Q3 		$7.97M Sell
165,964
-180
-0.1% -$8.7K 0.53% 55
2021
Q2 		$6.96M Buy
166,144
+3,180
+2% +$123K 0.45% 62
2021
Q1 		$5.49M Sell
162,964
-5,694
-3% -$203K 0.41% 66
2020
Q4 		$5.89M Sell
168,658
-260
-0.2% -$8.99K 0.46% 59
2020
Q3 		$5.86M Sell
168,918
-1,898
-1% -$63.3K 0.53% 54
2020
Q2 		$5.59M Sell
170,816
-5,168
-3% -$165K 0.51% 58
2020
Q1 		$5.3M Sell
175,984
-9,470
-5% -$282K 0.54% 54
2019
Q4 		$5.37M Sell
185,454
-1,840
-1% -$50.9K 0.27% 72
2019
Q3 		$4.84M Sell
187,294
-19,310
-9% -$488K 0.21% 76
2019
Q2 		$5.27M Sell
206,604
-36,868
-15% -$911K 0.21% 79
2019
Q1 		$6.37M Buy
243,472
+1,134
+0.5% +$27.9K 0.25% 75
2018
Q4 		$5.58M Sell
242,338
-21,790
-8% -$484K 0.24% 76
2018
Q3 		$6.23M Sell
264,128
-6,560
-2% -$160K 0.19% 84
2018
Q2 		$6.24M Buy
270,688
+9,848
+4% +$234K 0.2% 83
2018
Q1 		$6.42M Sell
260,840
-31,100
-11% -$817K 0.22% 86
2017
Q4 		$7.83M Buy
291,940
+2,610
+0.9% +$66.4K 0.24% 78
2017
Q3 		$6.97M Sell
289,330
-3,640
-1% -$82.3K 0.21% 75
2017
Q2 		$6.28M Sell
292,970
-11,168
-4% -$225K 0.18% 87
2017
Q1 		$5.21M Sell
304,138
-18,570
-6% -$323K 0.14% 99
2016
Q4 		$5.79M Sell
322,708
-51,660
-14% -$937K 0.16% 95
2016
Q3 		$7.79M Sell
374,368
-76,234
-17% -$1.89M 0.22% 79
2016
Q2 		$12.1M Buy
450,602
+15,738
+4% +$432K 0.36% 55
2016
Q1 		$11.8M Sell
434,864
-6,276
-1% -$168K 0.42% 52
2015
Q4 		$12.8M Sell
441,140
-2,230
-0.5% -$61.7K 0.44% 49
2015
Q3 		$12M Buy
443,370
+710
+0.2% +$20.1K 0.4% 52
2015
Q2 		$12.1M Buy
442,660
+31,262
+8% +$879K 0.31% 57
2015
Q1 		$11M Buy
411,398
+2,000
+0.5% +$46.1K 0.29% 58
2014
Q4 		$8.66M Buy
409,398
+2,204
+0.5% +$49.2K 0.22% 73
2014
Q3 		$9.7M Sell
407,194
-96
-0% -$2.21K 0.23% 68
2014
Q2 		$9.41M Sell
407,290
-3,016
-0.7% -$66.6K 0.24% 65
2014
Q1 		$9.37M Sell
410,306
-57,164
-12% -$1.22M 0.29% 58
2013
Q4 		$8.64M Sell
467,470
-17,350
-4% -$302K 0.27% 70
2013
Q3 		$8.2M Sell
484,820
-27,210
-5% -$458K 0.29% 61
2013
Q2 		$7.93M Buy
+512,030
New +$8.52M 0.3% 58

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Eagle Global Advisors's NVO Position: Q2 2026 in Review

Eagle Global Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 6,205 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #240.

Eagle Global Advisors first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.8M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Eagle Global Advisors held 6,205 shares of Novo Nordisk worth $297K as of Q2 2026.
  • Eagle Global Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Eagle Global Advisors's portfolio in Q2 2026, its #240 holding.
  • Eagle Global Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Eagle Global Advisors's Novo Nordisk position peaked at $15.8M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.